| | | | | |
PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated | $9,1400 | +0,00% | $118,87M | $25,55K | |
PLYX Polaryx Therapeutics, Inc. Common Stock | $2,3200 | +0,43% | $118,83M | $193,48K | |
PGAC Pantages Capital Acquisition Corporation Class A Ordinary Shares | $10,7000 | +0,19% | $118,41M | $2,93K | |
DMO Western Asset Mortgage Opportunity Fund Inc. | $10,3400 | +0,00% | $118,27M | $70,14K | |
ENGN enGene Therapeutics Inc. Common Stock | $1,7900 | +0,00% | $117,90M | $292,69K | |
ANIX Anixa Biosciences, Inc. | $3,4500 | +0,88% | $117,71M | $170,21K | |
OPRX OptimizeRx Corporation Common Stock | $6,0400 | -0,17% | $117,65M | $264,77K | |
| $0,97990 | -0,32% | $117,55M | $810,42K | |
JELD JELD-WEN Holding, Inc. | $1,4200 | +0,00% | $117,16M | $676,91K | |
MCN XAI Madison Equity Premium Income Fund | $5,6400 | +0,00% | $117,14M | $67,83K | |
WSBK Winchester Bancorp, Inc. Common Stock | $13,0300 | +0,23% | $117,11M | $3,82K | |
NEOV NeoVolta Inc. Common Stock | $2,0900 | -0,95% | $116,95M | $465,15K | |
BRKH Burtech Acquisition Corp II Class A Ordinary Shares | $9,9400 | +0,00% | $116,90M | $125,43K | |
| $7,7800 | +0,00% | $116,86M | $23,33K | |
MBOT Microbot Medical, Inc. Common Stock | $1,7100 | -0,58% | $116,86M | $297,71K | |
